Home » Topics » BioWorld Science

BioWorld Science
RSS

New RET kinase inhibitors identified at Blueprint Medicines

Feb. 9, 2018

FDA priority review granted for antimalarial tafenoquine

Feb. 9, 2018

Q Biomed receives exclusive option for glaucoma biomarker GDF-15

Feb. 9, 2018

Columbia University divulges novel CKI-epsilon inhibitors

Feb. 9, 2018

Sanofi files tender offer for Bioverativ

Feb. 9, 2018

Rebinyn launched in the U.S.for the treatment of hemophilia B

Feb. 9, 2018

V ClinBio acquires 49.98% equity stake in Cellix Bio

Feb. 9, 2018

New phase II umbrella trial studies novel agents for the management of relapsed ovarian cancer

Feb. 9, 2018

Daiichi Sankyo studies DS-1205c with osimertinib for metastatic or unresectable EGFR-mutant NSCLC

Feb. 9, 2018

FDA accepts SIGA Technologies' NDA for TPOXX

Feb. 9, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...